Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Carlisle JW, Leal T. Advancing immunotherapy in small cell lung cancer. Cancer. 2023;129(22):3525–34.
2. Saida Y, Watanabe S, Kikuchi T. Extensive-stage small-cell lung cancer: current landscape and future prospects. Onco Targets Ther. 2023;16:657–71.
3. Dingemans AC, Fruh M, Ardizzoni A, et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol. 2021;32(7):839–53.
4. National Comprehensive Cancer Network. Small cell lung cancer NCCN guidelines Version 2.2024. 2024. https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf. Accessed 6 June 2024.
5. Rudin CM, Reck M, Johnson ML, et al. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer. J Hematol Oncol. 2023;16(1):66.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献